| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3087369
Max Phase: Preclinical
Molecular Formula: C26H35N4O3+
Molecular Weight: 451.59
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cnccn1
Standard InChI: InChI=1S/C26H34N4O3/c31-24(29-23-17-27-13-14-28-23)19-30-15-9-20(10-16-30)22(18-30)33-25(32)26(21-7-3-4-8-21)11-5-1-2-6-12-26/h3-4,7,13-14,17,20,22H,1-2,5-6,8-12,15-16,18-19H2/p+1/t20?,22-,30?/m0/s1
Standard InChI Key: IQKHJOKQTJCWTF-HHBNHXTQSA-O
Associated Targets(Human)
Liver microsome 8277 Activities
Muscarinic acetylcholine receptor M3 7750 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Cavia porcellus 23802 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Muscarinic acetylcholine receptor M3 1154 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 451.59 | Molecular Weight (Monoisotopic): 451.2704 | AlogP: 3.79 | #Rotatable Bonds: 6 |
| Polar Surface Area: 81.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.49 | CX Basic pKa: 0.04 | CX LogP: -1.29 | CX LogD: -1.27 |
| Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.40 | Np Likeness Score: 0.20 |
References
| 1. Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V.. (2013) The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD., 23 (23): [PMID:24144851] [10.1016/j.bmcl.2013.09.092] |
Source
Source(1):